Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Evogene Ltd (NYSE:EVGN)

5.25
Delayed Data
As of 1:32pm ET
 -0.06 / -1.13%
Today’s Change
5.11
Today|||52-Week Range
9.32
-34.78%
Year-to-Date
No recent news for Evogene Ltd.

Today’s Trading

Previous close5.31
Today’s open5.34
Day’s range5.11 - 5.36
Volume9,633
Average volume (3 months)4,524
Market cap$135.2M
Dividend yield--
Data as of 1:32pm ET, 12/06/2016

Growth & Valuation

Earnings growth (last year)-17.24%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-23.31%
P/E ratio--
Price/Sales18.24
Price/Book1.30

Competitors

 Today’s
change
Today’s
% change
VBLTVascular Biogenics L...-0.25-4.76%
QUREUniqure NV+0.22+3.87%
ENZYEnzymotec Ltd+0.05+0.79%
PSTIPluristem Therapeuti...-0.01-0.65%
Data as of 2:53pm ET, 12/06/2016

Financials

Next reporting dateMarch 22, 2017
EPS forecast (this quarter)-$0.18
Annual revenue (last year)$11.1M
Annual profit (last year)-$17.2M
Net profit margin-154.67%

Profile

Sector
Health Technology
Industry
Biotechnology
President &
Chief Executive Officer
Ofer Haviv
Chief Operating Officer
Yuval Ben-Galim
Corporate headquarters
Rehovot, Tel Aviv

Forecasts


Search for Jobs